The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of NKTR, GSKY, RBBN (SONS), MDR and TX

NEW YORK, Dec. 10, 2018 (GLOBE NEWSWIRE) -- The Klein Law Firm announces that class action complaints have been filed on behalf of shareholders of the following companies. If you suffered a loss you have until the lead plaintiff deadline to request that the court appoint you as lead plaintiff.

Nektar Therapeutics (NASDAQ: NKTR)
Class Period: November 11, 2017 to October 2, 2018
Lead Plaintiff Deadline: December 31, 2018

Nektar Therapeutics allegedly made materially false and/or misleading statements and/or failed to disclose that: (1) prior studies which attempted to pegylate IL-2 failed; (2) the extended half-life of the Company's lead I-O candidate, NKTR-214, was unlikely to result in efficacy and created additional high-dosing safety concerns; (3) NKTR-214 was less effective than IL-2 alone; (4) the combination of NKTR-214 with nivolumab has yet to demonstrate significant positive results; and (5) as a result, Nektar’s public statements as set forth above were materially false and misleading at all relevant times.

Get additional information about the NKTR lawsuit: http://www.kleinstocklaw.com/pslra-1/nektar-therapeutics-loss-submission-form?wire=3

GreenSky, Inc. (NASDAQGS: GSKY)
Class Period: Class A common shareholders who purchased shares pursuant to the IPO on or around May 23, 2018
Lead Plaintiff Deadline: January 28, 2019

The complaint alleges that the Offering Documents failed to disclose material information and/or misstated material information, including the substantial change in the composition of GreenSky’s merchant business mix and the resulting diminution in transaction-fee revenue. The Initial Public Offering closed on May 29, 2018 with GreenSky having sold 43.7 million shares of Class A common stock at $23.00 per share.

On November 6, 2018, GreenSky issued a press release indicating that the Company’s transaction-fee rate was approximately 35 basis points below the rate achieved in the third quarter of 2017. Following this news, shares of GreenSky closed at $9.28 per share on November 6, 2018.

Get additional information about the GSKY lawsuit: http://www.kleinstocklaw.com/pslra-1/greensky-inc-loss-submission-form?wire=3

Ribbon Communications, Inc. (NASDAQ: RBBN) formerly Sonus Networks, Inc. (NASDAQ: SONS)
Class Period: January 8, 2015 to March 24, 2015
Lead Plaintiff Deadline: January 7, 2019

The lawsuit alleges that throughout the class period, Sonus Networks, Inc. made materially false and/or misleading statements and/or failed to disclose that: (1) the Company would fall materially short of its $74 million revenue forecast; (2) defendants knew that unrealistic revenue and profitability forecasts remained aspirational and largely unreachable, a fact that senior sales personnel regularly communicated to Defendants; (3) a number of 2015 sales had been “pulled forward” to buoy sales numbers in Q4 2014, at management’s express direction, and (4) the “backlog” of sales expected to be recognized in early 2015 was significantly lower than usual.

Get additional information about the RBBN/SONS lawsuit: http://www.kleinstocklaw.com/pslra-1/sonus-networks-inc-loss-submission-form?wire=3

McDermott International, Inc. (NYSE: MDR)
Class Period: January 24, 2018 to October 30, 2018
Lead Plaintiff Deadline: January 15, 2019

The complaint alleges that during the class period McDermott International, Inc. made materially false and/or misleading statements and/or failed to disclose that: (1) the Company was facing strong headwinds and would fail to meet revenue and earnings estimates; (2) there were material problems with the integration of the CB&I business; (3) certain CB&I projects were reasonably likely to incur higher costs; (4) as a result, the fair value of these CB&I projects would be materially impacted; and (5) as a result of the foregoing, Defendants' positive statements about the Company's business, operations, and prospects were materially misleading and/or lacked a reasonable basis.

Get additional information about the MDR lawsuit: http://www.kleinstocklaw.com/pslra-1/mcdermott-international-inc-loss-submission-form?wire=3

Ternium S.A. (NYSE: TX)
Class Period: May 1, 2014 to November 27, 2018
Lead Plaintiff Deadline: January 28, 2019

The complaint alleges that throughout the class period Ternium S.A. made materially false and/or misleading statements and/or failed to disclose that: (1) Defendant Paolo Rocca, Ternium’s Chairman, knew that one of his company’s executives paid cash to government officials from 2009 to 2012 to expedite compensation payments for the sale of Ternium’s Sidor unit; (2) this conduct would lead Rocca to be charged in a graft scheme and subject Ternium, its affiliates, and/or its executives to heightened governmental scrutiny; and (3) as a result, Ternium’s public statements were materially false and/or misleading at all relevant times.  

On November 27, 2018, Bloomberg reported that Rocca was indicted for his role in a graft scheme. According to the article, “The judge charged Rocca after the Argentine billionaire testified that one of his company’s executives paid an undisclosed amount of cash to government officials in monthly installments from 2009 to 2012. The officials were allegedly working for then-President Cristina Fernandez de Kirchner’s administration to speed up a compensation payment from Venezuela’s Hugo Chavez for the nationalization of Sidor, a unit that had been seized by Venezuela. Rocca’s group was compensated with $1.95 billion for the unit.”

Get additional information about the TX lawsuit: http://www.kleinstocklaw.com/pslra-1/ternium-s-a-loss-submission-form?wire=3

Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff. There is no cost or obligation to you. If you suffered a loss during the class period and wish to obtain additional information, please contact J. Klein, Esq. by telephone at 212-616-4899 or visit the webpages provided.

J. Klein, Esq. represents investors and participates in securities litigations involving financial fraud throughout the nation. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:
J. Klein, Esq.
Empire State Building
350 Fifth Avenue
59th Floor
New York, NY 10118
jk@kleinstocklaw.com
Telephone: (212) 616-4899
Fax: (347) 558-9665
www.kleinstocklaw.com